Regencell Bioscience Holdings (RGC) Invested Capital (2020 - 2021)
Regencell Bioscience Holdings' (RGC) quarterly Invested Capital came in at $431969.0 in Q2 2021, down 85.93% YoY from $3.1 million in Q2 2020, and down 85.93% on a QoQ basis from $3.1 million in Q2 2020.
Regencell Bioscience Holdings (RGC) Invested Capital (2020 - 2021) Analysis & Trends
Regencell Bioscience Holdings (RGC) has 2 years of Invested Capital data on file, last reported at $431969.0 in Q2 2021.
- Quarterly Invested Capital fell 85.93% year-over-year to $431969.0 in Q2 2021, while the trailing twelve-month figure through Jun 2024 was $431969.0 (down 87.66% YoY) and the FY2021 annual result came in at $431969.0, down 85.93% from the prior year.
- Invested Capital slipped to $431969.0 in Q2 2021, from $3.1 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $3.1 million in Q2 2020 to a low of $431969.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 630.00 Mn |
| 10 | Regencell Bioscience Holdings | 2.69 Bn | 2.69 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 431,969.00 |
| Jun 30, 2020 | 3.07 Mn |